User:Michael Strong/TB
Web Supplement to:
Comprehensive Structural Analysis of Drug-Resistant Mutations in Mycobacterium tuberculosis.
Michael Strong 1,2, Andreas Sandgren 3,4, James E. Galagan 5,6, Mark Borowsky 5,7,8, George M. Church 2, Megan B. Murray 3,
1.Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, 80206,
2.Department of Genetics, Harvard Medical School, Boston, MA 02115,
3.Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115,
4.European Centre for Disease Prevention and Control,
5.Broad Institute of MIT and Harvard, Cambridge, MA, 02142,
6.College of Engineering, Boston University, Boston, MA, 02118,
7.Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, 02114,
8.Department of Genetics, Massachusetts General Hospital, Boston, MA, 02114.
Correspondence regarding this webpage can be sent to: StrongM@NJHealth.org
Please click on the GREEN links to see the structural details described.
RpoB homology model with Rifampin bound
|
RpoB homology model with rifampin bound
RpoB homology model with resistance mutations
GidB homology model with S-adenosylmethionine bound
|
GidB homology model with S-adenosylmethionine bound
GidB homology model with resistance mutations
GidB S-adenosylmethionine binding site
GidB homology model with resistance mutations (Space Fill Representation)
RpsL homology model with streptomycin
|
RpsL homology model with streptomycin
RpsL homology model with resistance mutations
InhA crystal structure with ETH-NAD bound
|
InhA with ETH-NAD with drug resistance mutations
Resistance Mutations Ser94Ala, Ile95Pro
InhA crystal structure with INH-NAD bound
|
InhA with INH-NAD with drug resistance mutations in red
GyrA crystal structure
|
GyrA homodimer with resistance mutations
GyrA homodimer quinolone binding and resistance region
KatG crystal structure with heme bound
|
KatG dimer with bound heme molecules
KatG with Isoniazid Resistance Mutations in Red
PncA crystal structure
|
PncA crystal structure with resistance mutations
PncA crystal structure with resistance mutations and catalytic cysteine
PncA crystal structure with mutations and catalytic cysteine indicated (Space Fill Representation)